Skip to main content
. 2019 Oct 1;10:1235. doi: 10.3389/fphys.2019.01235

TABLE 1.

COPD patients’ details.

Patient Gender Age (years) Smoking status GOLD stage Treatment
#1 M 84 Former 3 Corticosteroid + LABA + LAMA
#2 M 72 Former 3 LABA + LAMA
#3 F 71 Former 2 LABA + LAMA
#4 M 63 Smoker 3 Corticosteroid + LABA + LAMA
#5 F 44 Smoker 1 Corticosteroid + LABA
#6 M 76 No Smoker 2 Corticosteroid + LABA + LAMA
#7 F 75 Former 2 Corticosteroid + LABA + LAMA
#8 M 69 Former 3 Corticosteroid + LABA + LAMA

LABA, long-acting β2-agonist; LAMA, long-acting anti-muscarinic agent.